QuidelOrtho Corporation (QDEL) delivered adjusted earnings per share (EPS) of 74 cents in first-quarter 2025, up 68.2% year over year. The figure topped the Zacks Consensus Estimate by 27.6%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)The adjustments include expenses related to the amortization of intangibles, and acquisition and integration costs, among others.GAAP loss per share for the quarter was 19 cents compared with the year-earlier loss of $25.5 per share.QDEL’s Revenue ...

QuidelOrtho (QDEL) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 27.59%. A quarter ago, it was expected that this medical diagnostics company would post earnings of $0.55 per share when it actually produced earnings of $0.63, delivering a surprise of 14.55%.Over the last four quarte ...

May 7, 2025 QuidelOrtho First Quarter 2025 Financial Results QuidelOrtho – Proprietary & Confidential. | © 2025. All Rights Reserved. 2 $160M 2 Total Revenue $693M North America 57% Other 19% China 12% EMEA 12% Recurring 82% Business Unit Geography Category Labs 51% Point of Care 26% 4 Adjusted EBITDA 23% Margin2 3 Forward-Looking Statements and Non-GAAP Financial Measures Forward-Looking Statements: This presentation of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") contains "forward-looking stat ...

QuidelOrtho (QDEL) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Welcome to the Quintel Ortho First Quarter twenty twenty five Financial Results Conference Call and Webcast. At this time, all participant lines are in listen mode only. For those of you participating in the conference call, there will be an opportunity for questions at the end of the prepared remarks. Please note this conference call is being recorded. An audio replay for the conference call will be available on the company's websit ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? QuidelOrtho (QDEL) , which belongs to the Zacks Medical - Products industry, could be a great candidate to consider.This medical diagnostics company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 94.37%.For the most recent quarter, QuidelOrtho ...

QuidelOrtho (QDEL) shares ended the last trading session 10.1% higher at $28.85. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 29.7% loss over the past four weeks.The upside can be attributed to relief-rally across global markets following the announcement of a 90-day pause on tariff hike by the United States.This medical diagnostics company is expected to post quarterly earnings of $0.61 per share in its upcomin ...

QuidelOrtho (QDEL) recently launched the Results Manager System, a cutting-edge solution designed to streamline diagnostic data management and improve workflow efficiency in laboratories. This innovative system enhances connectivity, enabling seamless integration of test results from multiple sources for faster and more accurate decision-making.With the Results Manager System, QuidelOrtho aims to optimize laboratory operations and support better patient outcomes. By simplifying data handling and reducing ma ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 29, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number: 001-41409 QUIDELORTHO CORPORATION (Exact name of registrant as specified in its charter) De ...

Healthcare in vitro diagnostics company QuidelOrtho (QDEL 4.28%) attracted the right kind of attention from investors after posting its latest quarterly earnings report on Thursday. A rather encouraged market traded the company's shares up by more than 4% in response. That was more than good enough to top the S&P 500 index's slightly over 1% increase.Narrower-than-expected declinesQuidelOrtho's fourth-quarter and full-year results, unveiled after market close on Wednesday, showed that the company earned $70 ...

QuidelOrtho Corporation (QDEL) delivered adjusted earnings per share (EPS) of 63 cents in the fourth quarter of 2024, down 46.2% year over year. The figure, however, topped the Zacks Consensus Estimate by 14.6%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The adjustments include expenses related to the amortization of intangibles, and acquisition and integration costs, among others.GAAP loss per share for the quarter was $2.28 against the year-earlier EPS of 10 cents.Full-year 2024 ...